|
|
5-day change | 1st Jan Change | ||
|
76.16 USD |
-0.54% | +1.45% | +10.34% | |
Published on 05/08/2025 at 12:30
This article is reserved for members Unlock the article: REGISTER NOW!
© Reuters – 2025
|
Land & Buildings Investment Management Says Glass Lewis Recommends National Health Investors’s Shareholders Voting ‘FOR’ It’s Nominees |
12:30pm |
RE |
|
Land & Buildings Gives an Oral Presentation to Shareholders of National Health Investors |
May. 07 |
CI |
|
National Health Investors, Inc., Q1 2025 Earnings Call, May 06, 2025 |
May. 06 |
|
|
National Health Investors Q1 Normalized FFO, Revenue Rise; 2025 FFO Guidance Boosted |
May. 05 |
MT |
|
GUIDANCE (NHI) National Health Investors Lifts Normalized FFO 2025 Forecast to $4.68-$4.73 From $4.59-$4.66 vs. FactSet Est Adjusted FFO $4.73 |
May. 05 |
MT |
|
Earnings Flash (NHI) National Health Investors Reports Q1 Revenue $89.3M, vs. FactSet Est of $74.4M |
May. 05 |
MT |
|
Earnings Flash (NHI) National Health Investors Posts Q1 FFO $1.15, vs. FactSet Est of $1.13 |
May. 05 |
MT |
|
National Health Investors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 |
May. 05 |
CI |
|
Land & Buildings Issues an Investor Presentation to Shareholders of National Health Investors |
Apr. 24 |
CI |
|
Land & Buildings nominates two directors to medical REIT NHI’s board |
Apr. 09 |
RE |
|
National Health Investors Activist Shareholder Nominates Alternate Board Slate |
Apr. 09 |
MT |
|
Land & Buildings Sends Letter To National Health Investors Stockholders And Files Definitive Proxy Materials Detailing Urgent Need For Boardroom Change |
Apr. 09 |
RE |
|
Land & Buildings Sends Letter to Shareholders of National Health Investors |
Apr. 09 |
CI |
|
Land & Buildings Solicits Proxies from Shareholders of National Health Investors |
Apr. 08 |
CI |
|
National Health Files a Definitive Proxy Statement with Securities and Exchange Commission |
Apr. 08 |
CI |
|
Land & Buildings Solicits Proxies from Shareholders of National Health Investors |
Apr. 04 |
CI |
|
National Health Investors Commits $63.5 Million to Senior Living Portfolio |
Apr. 02 |
MT |
|
National Health Investors, Inc. acquired portfolio of six memory care communities with 205 units in Nebraska for $63.5 million. |
Apr. 01 |
CI |
|
National Health Investors, Inc. Appoints Robert W. Chapin, Jr. to Its Board of Directors and Special Committee, Effective March 27, 2025 |
Mar. 27 |
CI |
|
Truist Adjusts Price Target on National Health Investors to $76 From $70, Maintains Hold Rating |
Mar. 18 |
MT |
|
National Health Investors Unveils $46.3 Million Investment to Acquire Juniper Village at Paramus |
Mar. 17 |
MT |
|
National Health Investors, Inc. acquired Juniper Village at Paramus for $46.3 million. |
Mar. 16 |
CI |
|
National Health Investors, Inc., Q4 2024 Earnings Call, Feb 26, 2025 |
Feb. 26 |
|
|
National Health Investors Q4 Normalized FFO Rises; 2025 Guidance Set |
Feb. 26 |
MT |
|
Earnings Flash (NHI) National Health Investors Reports Q4 FFO $1.12, vs. FactSet Est of $1.10 |
Feb. 25 |
MT |
NHI: Dynamic Chart
National Health Investors, Inc. is a real estate investment trust. The Company specializes in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and lease, mortgage, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has 163 healthcare real estate properties located in 31 states and leased primarily pursuant to triple-net leases to 25 tenants. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The SHOP segment has 15 properties located in eight states with a combined 1,733 units.
More about the company
Buy
Average target price
80.86USD
Spread / Average Target
+5.59%
Consensus
Quarterly revenue – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
